Helen Branswell<p><a href="https://scicomm.xyz/tags/FDA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FDA</span></a> approves age extension for <a href="https://scicomm.xyz/tags/Moderna" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Moderna</span></a> <a href="https://scicomm.xyz/tags/RSV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RSV</span></a> vaccine to include adults aged 18-59 who have health conditions that increase their risk of severe disease. <a href="https://scicomm.xyz/tags/ACIP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ACIP</span></a> already voted to recommend use of RSV vaccine in adults aged 50-59 but that recommendation is in limbo. <a href="https://www.statnews.com/2025/06/12/fda-approves-moderna-rsv-vaccine-for-wider-age-range-18-and-older/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">statnews.com/2025/06/12/fda-ap</span><span class="invisible">proves-moderna-rsv-vaccine-for-wider-age-range-18-and-older/</span></a></p>